Senator calls for FDA ban on sale of cough-cold medicines for children under six
WASHINGTON Sen. Chris Dodd, D-Conn., senior member of the Senate Committee on Health, Education, Labor, and Pensions and chair of its subcommittee on Children and Families, earlier this week called on the Food and Drug Administration to ban the marketing of children’s cough-cold formulations for children under six even as industry made the announcement they would no longer market use of those medicines to children under four years of age.
“While I’m pleased to see that the drug companies are voluntarily taking some steps to ensure the safety and well being of our children, I am disappointed that the FDA has not followed the recommendations of its own advisory panel,” stated Dodd. “I strongly urge the FDA to take swift action to ensure the safety and efficacy of these products in young children before one more child is given a medicine that may not only be ineffective but could also be harmful.”
In a letter to FDA commissioner Andrew von Eschenbach, Dodd wrote, “Nearly a year has passed since the FDA’s Nonprescription Drugs Advisory Committee and Pediatric Advisory Committee voted 13 to 9 against the use of over-the-counter cough and cold medications in children ages two to six. Another cold and flu season is right around the corner, yet commonly available medical products continue to be marketed and sold to the parents of young children even though they have not been shown to be effective and experts have raised serious questions about their safety.”
ACE opens new rooms on Web site to promote germ fighting
WASHINGTON The Alliance for Consumer Education on Wednesday launched four new rooms on its interactive Web site, www.StopGerms.org, and unveiled a 3-dimensional version of StopGerms.org in Second Life, a virtual online community. ACE’s StopGerms.org, is a website aimed at educating consumers on ways they can help keep their families healthy through proper hygiene practices within the home. Included in the new expansion to the popular interactive site are four new rooms: The Garage, Foyer, Study and Living Room.
Consumers can click on objects in each room such as doorknobs, carpets, toothbrushes, or counters to see which germs are hiding or lurking on each item. A second click of the mouse lets consumers know more about each of the germs and educates them on steps they can take to help protect their families from germs and the diseases they cause.
“ACE is helping parents and families understand the threat of exposure to those germs that can cause colds and flu,” stated Joseph Healy, ACE president.
ACE is a nonprofit foundation dedicated to advancing community health and well-being.
GelStat makes plans to turn around business and drive sales
GelStat Corporation chief executive officer Gerald Kieft on Tuesday outlined the company’s turnaround plans in an open letter to shareholders.
“While we have encountered a number of challenges expected with any turnaround situation, we are pleased to report the core fundamentals are sound and we are more excited than ever about the company’s prospects,” he wrote.
To date, the company has re-established distribution and product availability through Drugstore.com and Amazon.com and performed a physical inventory audit Sept. 13, tablulating 942,120 boxes of GelStat Migraine four count and GelStat Migraine eight count collectively. Kieft estimated the potential revenue from the sale of this inventory would fall between $3.2 million and $10 million depending on the sales channel.
Moving forward, GelStat plans to drive direct-to-consumer sales through cost per acquisition Internet campaigns, infomercials, television, radio and print advertising and to reseed its products through wholesalers and other distribution channels into retail.